NovaScan is Awarded Two More Patents, Further Protecting Company Innovations
NovaScan, a clinical stage oncology company based in Chicago and Milwaukee, was recently awarded patents for electrical scanning across tissue and for leverage of Cole frequency measurements to predict the likelihood of cancer recurrence. Patent No. 10,758,151 is a...
NovaScan welcomes Dr Charles Link to lead efforts in targeted drug delivery and to the NovaScan Board of Directors
NovaScan, an emerging clinical stage oncology company, is pleased to announce that Charles ‘Chuck’ Link MD, FACS has joined the Board of Directors of NovaScan. Dr Link is also a member of the NovaScan Executive Committee. Additionally, Chuck will lead NovaScan’s...
NovaScan Wins First Prize and Third Place in two International Competitions
November 15, 2019 NovaScan, an oncology company based in Chicago and Milwaukee, was awarded first prize in the BioPharma category in the InnoStars competition and third prize in the Innovate Hubei International Tech and Innovation Competition (InnoHubei), both in...
NovaScan Presented at American Society of Breast Surgeons Annual Meeting
NovaScan recently presented in a poster session at the 2018 Annual Meeting of the American Society of Breast Surgeons, where the company presented the results of a retrospective study that demonstrated that an elevated Cole frequency — which can be detected at the...
NovaScan Clincal Results Published in top Dermatology Journal
NovaScan’s clinical results in Mohs surgery were published in the highly regarded Journal of the American Academy of Dermatology. The article, titled "Bioimpedance Measurement as an Assessment of Margin Positivity in Mohs Surgical Specimens of Non-Melanoma Skin...
NovaScan in the Press
NovaScan was recently featured in the Milwaukee Journal Sentinel, describing our recent progress in commercializing our MarginScan device for use in Mohs procedures for skin cancer.
Poster Session at the ACMS Annual Meeting
NovaScan participated in a poster session at the 2017 American College of Mohs Surgeons Annual Meeting, where the company presented A Rapid Method for Detecting Non-Melanoma Skin Cancer in Mohs Micrographic Surgery. The poster, which demonstrates how NovaScan can...
NovaScan’s Dr. John Shell to Present at NIH Sponsored Conference
NovaScan Senior Scientist John Shell, Ph.D. has been selected to present in a poster session at a Special Topics Conference on Healthcare Innovations and Point of Care Technologies, co-sponsored by the National Institute of Health and IEEE. Dr. Shell will be...